iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Trading 1.1% Higher

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) shares traded up 1.1% during mid-day trading on Tuesday . The stock traded as high as $64.08 and last traded at $63.92. 16,032 shares traded hands during trading, a decline of 78% from the average session volume of 71,795 shares. The stock had previously closed at $63.25.

iShares U.S. Pharmaceuticals ETF Stock Performance

The company has a 50 day moving average of $66.77 and a 200-day moving average of $62.87. The stock has a market cap of $634.79 million, a price-to-earnings ratio of 6.23 and a beta of 0.59.

Institutional Investors Weigh In On iShares U.S. Pharmaceuticals ETF

A number of hedge funds have recently bought and sold shares of the stock. Spire Wealth Management raised its position in iShares U.S. Pharmaceuticals ETF by 543.4% in the 1st quarter. Spire Wealth Management now owns 2,194 shares of the company’s stock valued at $149,000 after purchasing an additional 1,853 shares in the last quarter. Essex Financial Services Inc. raised its position in shares of iShares U.S. Pharmaceuticals ETF by 200.0% during the 1st quarter. Essex Financial Services Inc. now owns 4,101 shares of the company’s stock worth $278,000 after acquiring an additional 2,734 shares in the last quarter. Global Retirement Partners LLC raised its position in shares of iShares U.S. Pharmaceuticals ETF by 454.1% during the 1st quarter. Global Retirement Partners LLC now owns 410 shares of the company’s stock worth $28,000 after acquiring an additional 336 shares in the last quarter. Fifth Third Bancorp raised its position in shares of iShares U.S. Pharmaceuticals ETF by 2,444.0% during the 1st quarter. Fifth Third Bancorp now owns 1,272 shares of the company’s stock worth $86,000 after acquiring an additional 1,222 shares in the last quarter. Finally, Accurate Wealth Management LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF during the 1st quarter worth about $7,364,000.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.